patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Pluristem Life Systems, Inc. Stock Quotes

For access to level II stock quotes, you must have attained an Agoracom ranking of at least Treasurer.